UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

 

For the month of August

 

Commission File Number 001-37518

 

Benitec Biopharma Limited
(Translation of registrant’s name into English)

 

F6A, 1-15 Barr Street
Balmain, NSW 2041
Australia

 (Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x     Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨     No x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): n/a

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Benitec Biopharma Limited
     
     
Date: 8/10/2016 By:

/s/ GREG WEST

  Name:   Greg West
  Title: Company Secretary

 

 

 

 

EXHIBIT INDEX

Exhibit

Number

 

Description

99.1  

Benitec announces restructuring of Senior Executive team

 

 

 

Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Benitec Biopharma Charts.
Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Benitec Biopharma Charts.